Process for the production of atorvastatin calcium in amorphous form

Details for Australian Patent Application No. 2004317570 (hide)

Owner Ranbaxy Laboratories Limited

Inventors Kumar, Yatendra; Kumar, Saridi Madhava Dileep; Sathyanarayana, Swargam

Agent Callinan

Pub. Number AU-B-2004317570

PCT Pub. Number WO2005/092852

Priority 491/Del/2004 17.03.04 IN

Filing date 19 November 2004

Wipo publication date 6 October 2005

Acceptance publication date 6 January 2011

International Classifications

C07D 207/34 (2006.01) Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom

A61K 31/40 (2006.01) - having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil

Event Publications

26 October 2006 PCT application entered the National Phase

  PCT publication WO2005/092852 Priority application(s): WO2005/092852

6 January 2011 Application Accepted

  Published as AU-B-2004317570

12 May 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004317574-Process and plant for producing a refuse derived solid fuel

2004317562-Internal layout of an aircraft cabin